Clinical Trial Update: A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

View source ↗

Summary

A clinical trial evaluating bempedoic acid in combination with ezetimibe and either rosuvastatin or atorvastatin in people with primary hypercholesterolemia or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Bempedoic Acid (bempedoic acid)
• EZETIMIBE (EZETIMIBE)
• Rosuvastatin (rosuvastatin)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | Conditions: Primary Hypercholesterolemiia, Mixed Dyslipidemia | Status: RECRUITING